Migraine and structural abnormalities in the brain

Current Opinion in Neurology

Volumn 27, Issue 3, 2014, Pages 309-314

  Hougaard, Anders ^a   Amin, Faisal Mohammad ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

brain structure; cortical thickness; migraine; MRI; voxel based morphometry; white matter hyperintensities

Indexed keywords

BRAIN INFARCTION; BRAIN MALFORMATION; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; GRAY MATTER; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; MIGRAINE; NEUROIMAGING; PATIENT CARE; REVIEW; RISK FACTOR; WHITE MATTER; BRAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

BRAIN; BRAIN INFARCTION; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MIGRAINE DISORDERS; WHITE MATTER;

EID: 84900509168     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000086     Document Type: Review

References (56)

1. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000; 11:805-821.
2. Eriksson SH, Free SL, Thom M, Symms MR. Quantitative grey matter histological measures do not correlate with grey matter probability values from in vivo MRI in the temporal lobe. J Neurosci 2009; 1:111-118.
3. Franklin TR, Wang Z, Shin J, et al. A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct 2013; 218:97-104.
4. Bennett CM, Wolford GL, Miller MB. The principled control of false positives in neuroimaging. Soc Cogn Affect Neurosci 2009; 4:417-422.
5. Rocca MA. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke 2006; 37:1765-1770.
6. Jin C, Yuan K, Zhao L, et al. Structural and functional abnormalities in migraine patients without aura. NMR Biomed 2012; 26:58-64.
7. Matharu MS, Good CD, May A, et al. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol 2003; 10:53-57.
8. Schmidt-Wilcke T, Gänßbauer S, Neuner T, et al. Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia 2008; 28:1-4.
9. Schmitz N, Admiraal-Behloul F, Arkink EB, et al. Attack frequency and disease duration as indicators for brain damage in migraine. Headache 2008; 48:1044-1055.
10. Schmitz N, Arkink EB, Mulder M, et al. Frontal lobe structure and executive function in migraine patients. Neurosci Lett 2008; 440:92-96.
11. Valfrè W, Rainero I, Bergui M, Pinessi L. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 2007; 48:109-117.
12. Kim J, Suh S-I, Seol H, et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia 2008; 28:598-604.
13. Schmidt-Wilcke T, Hierlmeier S, Leinisch E. Altered regional brain morphology in patients with chronic facial pain. Headache 2010; 50:1278-1285.
14. Liu J, Lan L, Li G, et al. Migraine-related gray matter and white matter changes at a 1-year follow-up evaluation. J Pain 2013; 14:1703-1708.
15. Granziera C, DaSilva AFM, Snyder J, et al. Anatomical alterations of the visual motion processing network inmigraine with and without aura. Plos Med 2006; 3:e402.
16. DaSilva AFM, Granziera C, Snyder J, Hadjikhani N. Thickening in the soma-tosensory cortex of patients with migraine. Neurology 2007; 69:1990-1995.
17. Datta R, Detre JA, Aguirre GK, Cucchiara B. Absence of changes in cortical thickness in patients with migraine. Cephalalgia 2011; 31:1452-1458.
18. Messina R, Rocca MA, Colombo B, et al. Cortical abnormalities in patients with migraine: a surface-based analysis. Radiology 2013; 268:170-180.
19. Maleki N, Becerra L, Brawn J, et al. Concurrent functional and structural cortical alterations in migraine. Cephalalgia 2012; 32:607-620.
20. Maleki N, Linnman C, Brawn J, et al. Her versus his migraine: multiple sex differences in brain function and structure. Brain 2012; 135:2546-2559.
21. Granziera C, Daducci A, Romascano D, et al. Structural abnormalities in the thalamus of migraineurs with aura: A multiparametric study at 3 T. Hum Brain Mapp 2014; 35:1461-1468.
22. Yuan K, Zhao L, Cheng P, et al. Altered structure and resting-state functional connectivity of the basal ganglia in migraine patients without aura. J Pain 2013; 14:836-844.
23. Maleki N, Becerra L, Brawn J, et al. Common hippocampal structural and functional changes in migraine. Brain Struct Funct 2012; 218:903-912.
24. Garde E, Mortensen EL, Krabbe K, et al. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000; 356:628-634.
25. Ylikoski A, Erkinjuntti T, Raininko R, et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26:1171-1177.
26. Launer LJ. Epidemiology of white matter lesions. Top Magn Reson Imaging 2004; 6:365-367.
27. Debette S, Markus HS. The clinical importance of white matter hyperinten-sities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J 2010; 341:c3666.
28. Soges LJ, Cacayorin ED, Petro GR. Migraine: evaluation by MR. AJNR Am J Neuroradiol 1988; 9:425-429.
29. Igarashi H, Sakai F, Kan S, et al. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991; 11:69-74.
30. Pavese N, Canapicchi R, Nuti A, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia 1994; 14:342-345.
31. Rossato G, Adami A, Thijs VN, et al. Cerebral distribution of white matter lesions in migraine with aura patients. Cephalalgia 2010; 30:855-859.
32. Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. AJNR Am J Neuroradiol 1991; 12:521-524.
33. Ziegler DK, Batnitzky S, Barter R, McMillan JH. Magnetic resonance image abnormality in migraine with aura. Cephalalgia 1991; 11:147-150.
34. Cooney BS, Grossman RI, Farber RE, et al. Frequency of magnetic resonance imagingabnormalitiesinpatientswithmigraine. Headache1996;36:616-621.
35. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. J Am Med Assoc 2004; 291:427-434.
36. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. Br Med J 2011; 342:c7357.
37. Hamedani AG, Rose KM, Peterlin BL, et al. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013; 81:1308-1313.
38. Palm-Meinders IH, Koppen H, Terwindt GM, et al. Structural brain changes in migraine. J Am Med Assoc 2012; 308:1889-1897.
39. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology 2013; 81:1260-1268.
40. Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007; 6:611-619.
41. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002; 1:21-25.
42. Longstreth WT Jr, Bernick C, Manolio TA. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998; 9:1217-1225.
43. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001; 32:280-299.
44. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. J Am Med Assoc 2009; 301:2563-2570.
45. Gaist D, Pedersen L, Madsen C, et al. Long-term effects of migraine on cognitive function: a population-based study of Danish twins. Am Acad Neurol 2005; 64:600-607.
46. Baars MAE, van Boxtel MPJ, Jolles J. Migraine does not affect cognitive decline: results from the Maastricht aging study. Headache 2010; 50:176-184.
47. Rist PM, Dufouil C, Glymour MM, et al. Migraine and cognitive decline in the population-based EVA study. Cephalalgia 2011; 31:1291-1300.
48. Sándor PS, Mascia A, Seidel L. Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol 2001; 49:668-672.
49. Schurks M, Rist PM, Shapiro RE, Kurth T. Migraine and mortality: a systematic review and meta-analysis. Cephalalgia 2011; 31:1301-1314.
50. Donaghy M, Chang CL, Poulter N; European Collaborators of The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002; 73:747-750.
51. Kurth T, Schü rks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009; 73:581-588.
52. Tzourio C, Tehindrazanarivelo A, Iglé sias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. Br Med J 1995; 310:830-833.
53. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62:563-568.
54. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HGM, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006; 67:1128-1134.
55. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116 (Pt 1):187-202.
56. Kurth T, Chabriat H, Bousser M-G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol ; 11:92-100.